How large is the automated analyzers market, and what is its growth trajectory?
The automated analyzers market size has grown strongly in recent years. It will grow from $5.02 $ billion in 2024 to $5.39 $ billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing awareness of preventive healthcare, the growing geriatric population, rising demand for non-invasive diagnostic tests, expansion of clinical research, and expansion of drug development activities.
The automated analyzers market size is expected to see strong growth in the next few years. It will grow to $7.11 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to expansion of veterinary diagnostics, rising focus on reducing diagnostic errors, improving patient outcomes, growth of telemedicine, and remote monitoring. Major trends in the forecast period include novel biomarkers, point-of-care diagnostics, home-based diagnostic devices, miniaturization of diagnostic devices, and development of multi-analyte testing platforms.
Get Your Free Sample of The Global Automated Analyzers Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp
What are the key forces behind the automated analyzers market’s growth in recent years?
The rising prevalence of chronic diseases is expected to propel the growth of the automated analyzers market going forward. The prevalence of chronic diseases is rising due to aging populations, unhealthy lifestyles, and increased urbanization globally. Automated analyzers are used in chronic disease management for efficient and accurate diagnostic testing, enabling early detection, monitoring, and treatment of conditions like diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the rising prevalence of chronic diseases is driving the growth of the automated analyzers market.
What are the major segments of the automated analyzers market?
The automated analyzersmarket covered in this report is segmented –
1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types
2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types
3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems
2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers
3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers
4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report
Which companies dominate the automated analyzers market?
Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson, and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc., bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc
What major trends will shape the automated analyzers market during the forecast period?
Major companies operating in the automated analyzers market are focusing on developing innovative solutions such as automated clinical chemistry analyzers to enhance efficiency, accuracy, and throughput in diagnostic laboratories. Automated clinical chemistry analyzers refer to advanced instruments used in laboratories to perform a wide range of chemical tests on blood and other bodily fluids with minimal human intervention, enhancing efficiency and accuracy in diagnostic testing. For instance, in January 2024, Beckman Coulter, a US-based manufacturing company, launched the DxC 500 AU Chemistry Analyzer, which represents a cutting-edge advancement in automated clinical chemistry. Boasting over 120 high-quality assays, this analyzer is engineered to significantly enhance the capabilities of satellite and independent community hospital labs. It integrates sophisticated automation, streamlined workflows, and standardized reagents to boost testing efficiency and aid in clinical decision-making. By serving as a vital complement to central hub laboratories within healthcare systems that utilize hub-and-spoke models, the DxC 500 AU enhances overall efficiency and expands access to essential testing services.
What are the key regional dynamics of the automated analyzers market, and which region leads in market share?
North America was the largest region in the automated analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Automated Analyzers Market Report 2025 Offer?
The automated analyzers market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Automated analyzers are laboratory devices designed to perform repetitive analytical tests with minimal human intervention. They enhance efficiency by processing large volumes of samples accurately and rapidly. These systems are commonly used in clinical, chemical, and hematological analyses.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19322
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
